8-KItem 2.02 · Results of OperationsItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Cardinal Health reports higher fiscal 2026 earnings and sets 2027 guidance
Filed with the SEC on · Summarized by InvestorsBot
Cardinal Health reported fourth-quarter fiscal 2026 revenue of $63.7 billion, up 6%, and non-GAAP diluted EPS of $2.91, up 40%, including a $0.31-per-share benefit from a one-time IEEPA tariff refund; full-year non-GAAP EPS rose 37% to $11.26, or $10.95 excluding the refund. The company issued fiscal 2027 non-GAAP EPS guidance of $12.40 to $12.60, plans about $1 billion in share repurchases, and received board approval for an additional $5.0 billion repurchase authorization after completing $1.4 billion of buybacks in fiscal 2026.